NeuroPace, Inc. (NPCE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Rohin Patel
JPMorgan Chase & Co, Research Division

Hi, everyone. Welcome to the NeuroPace presentation. My name is Rohin Patel, medical device analyst at JPMorgan. Just to start off, it’s my pleasure to welcome CEO, Joel Becker, up to the stage for a presentation.

Joel Becker
CEO, President & Director

Thank you, Rohan, and thanks to you and to JPMorgan for having us here today. As Rohan mentioned, my name is Joel Becker, and I’m pleased to be here representing NeuroPace and the team at NeuroPace. These slides are also up on our website at neuropace.com, so you can find them there. As you do, please recognize the disclaimer, and thanks to all of you for being here today. I’m going to start as I’d like to start any discussion of NeuroPace with our most important slide. Our most important slide is the one that contains the mission of the business.

And it’s important that you all see it and read it because it’s really what catalyzes the activity that we engage in every day and guides our decision-making as well as energizes our efforts. And that’s the mission of transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. And we have a strong feeling and stewardship toward these patients and the clinicians that care for them. And that’s why we do what we do and have developed what we have here at NeuroPace.

The company and the business is led by an extraordinary team of people, some of whom